Sagittarius Life Science Corp (TPEX:3205)

Sagittarius Life Science Balance Sheet

Financials in millions TWD. Fiscal year is January - December.

Assets

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Cash & Equivalents	154.12	151.55	83.79	133.89	189.48	255.66
Short-Term Investments	481	652	77.11	81.49	80.24	99.25
Cash & Short-Term Investments	635.12	803.55	160.9	215.38	269.72	354.91
Cash Growth	-21.68%	399.40%	-25.30%	-20.14%	-24.00%	-9.98%
Accounts Receivable	157.91	11.77	52.03	50.36	47.15	53.68
Receivables	157.91	11.77	52.03	50.36	47.15	53.68
Inventory	83.67	8.98	31.05	31.54	27.94	28.57
Other Current Assets	5.43	3.16	6.84	35.59	29.81	10.98
Total Current Assets	882.12	827.45	250.82	332.87	374.61	448.15
Property, Plant & Equipment	55.06	90.86	109.61	114.2	118.42	128.83
Long-Term Investments	108.41	153.01	152.82	210.57	79.14	81.87
Other Intangible Assets	-	-	-	0.01	0.07	0.23
Other Long-Term Assets	91.79	0.39	6.57	7.08	6.89	16.68
Total Assets	1,137	1,072	519.83	664.72	579.12	675.75

Liabilities

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Accounts Payable	40.17	6.27	61.11	65.08	78.44	83.67
Current Portion of Leases	1.44	0.39	6.59	7.07	8.01	10.56
Current Income Taxes Payable	-	-	-	-	-	0.01
Current Unearned Revenue	0.01	0.1	0.44	0.67	1.41	-
Other Current Liabilities	19.75	19.23	23.86	54.3	28.55	31.69
Total Current Liabilities	133.28	25.99	92	127.13	116.4	125.94
Long-Term Leases	0.24	-	4.18	6.25	3.36	13.44
Other Long-Term Liabilities	0.92	0.92	3.89	4.44	3.94	4.66
Total Liabilities	134.44	26.91	100.07	137.82	123.71	144.03

Shareholders' Equity

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Common Stock	675.46	675.46	325.46	325.46	325.46	327.73
Additional Paid-In Capital	370.41	370.41	89.71	144.75	222.92	309.24
Retained Earnings	-47.89	-49.56	-48.53	-55.04	-79.6	-86.42
Treasury Stock	-	-	-	-	-	-8.74
Comprehensive Income & Other	3.1	45.99	41.72	99.49	-26.99	-25.03
Total Common Equity	1,001	1,042	408.35	514.65	441.79	516.78
Minority Interest	1.86	2.51	11.41	12.25	13.62	14.94
Shareholders' Equity	1,003	1,045	419.76	526.9	455.42	531.71
Total Liabilities & Equity	1,137	1,072	519.83	664.72	579.12	675.75

Additional Metrics

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Total Debt	73.6	0.39	10.77	13.32	11.37	24
Net Cash (Debt)	561.52	803.16	150.14	202.06	258.35	330.91
Net Cash Growth	-30.30%	434.96%	-25.70%	-21.79%	-21.93%	-7.20%
Net Cash Per Share	8.31	14.88	4.61	6.21	7.94	10.17
Filing Date Shares Outstanding	67.55	67.55	32.55	32.55	32.55	32.55
Total Common Shares Outstanding	67.55	67.55	32.55	32.55	32.55	32.55
Working Capital	748.84	801.46	158.82	205.74	258.21	322.21
Book Value Per Share	14.82	15.43	12.55	15.81	13.57	15.88
Tangible Book Value	1,001	1,042	408.35	514.65	441.73	516.55
Tangible Book Value Per Share	14.82	15.43	12.55	15.81	13.57	15.87
Land	41.31	37.8	37.8	37.8	37.8	37.8
Buildings	5.18	70.52	70.52	70.52	70.52	70.52
Machinery	25.51	25.51	51.05	47.71	67.65	66.84

Data Source: S&P Global Market Intelligence Last updated: Aug 14, 2026

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Sep 7, 2026

Data Sources Report a data error